Cargando…
In silico prediction of post-translational modifications in therapeutic antibodies
Monoclonal antibodies are susceptible to chemical and enzymatic modifications during manufacturing, storage, and shipping. Deamidation, isomerization, and oxidation can compromise the potency, efficacy, and safety of therapeutic antibodies. Recently, in silico tools have been used to identify liable...
Autor principal: | Vatsa, Shabdita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791605/ https://www.ncbi.nlm.nih.gov/pubmed/35040751 http://dx.doi.org/10.1080/19420862.2021.2023938 |
Ejemplares similares
-
Protein post-translational modifications: In silico prediction tools and molecular modeling
por: Audagnotto, Martina, et al.
Publicado: (2017) -
Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis
por: Gulhane, Pooja, et al.
Publicado: (2023) -
Raman Spectroscopy to Monitor Post-Translational Modifications
and Degradation in Monoclonal Antibody Therapeutics
por: McAvan, Bethan S., et al.
Publicado: (2020) -
Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer
por: Baietti, Maria Francesca, et al.
Publicado: (2023) -
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
por: Liu, Ruiqi, et al.
Publicado: (2023)